Richette Pascal

Rhumatologie

Hôpital Lariboisière
Paris, France

506 Activités

0 Followers

Scientifique

Digital

Production scientifique

Activités par an

Expertise

Sujets de recherche

Arthrose Goutte Arthrite Gonarthrose Polyarthrite rhumatoïde Arthrite psoriasique Rhumatismes Hyperuricémie Spondylarthrite

Collaborateurs

Bardin Thomas

Institut Mutualiste Montsouris, Paris, France

Ea Hang Korng

Hôpital Lariboisière, Paris, France

Latourte Augustin

Hôpital Lariboisière, Paris, France

Berenbaum Francis

Hôpital Saint-Antoine, Paris, France

Industries

Abbvie

58 collaboration(s)

Dernière en 2023

Janssen

44 collaboration(s)

Dernière en 2023

Novartis

43 collaboration(s)

Dernière en 2023

Lilly

29 collaboration(s)

Dernière en 2023

Dernières activités

A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs: A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Psoriatic Arthritis Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs

Essai Clinique (BMS) 20 mars 2024

Systemic inflammatory cytokine profiles in patients with gout during flare, intercritical and treat-to-target phases: TNFSF14 as new biomarker.

Annals of the rheumatic diseases 28 février 2024

Weight Loss for Patients with Gout and Concomitant Obesity: A Proof-of-Concept Randomized Trial.

Arthritis & rheumatology (Hoboken, N.J.) 02 janvier 2024

Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: data from the French Tw-IRD registry.

The Journal of infection 21 décembre 2023

Cardiovascular Safety of Febuxostat in Patients With Gout or Hyperuricemia: A Systematic Review of Randomized Controlled Trials.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 20 décembre 2023

L’inflammation induite par les cristaux d’urate monosodique et de pyrophosphate de calcium dépend du canal LRRC8A et du récepteur purinergique P2Y6